19:50 EDT Avenue Therapeutics trading halted, news pending
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATXI:
- Avenue Therapeutics Announces Reverse Stock Split
- Avenue Therapeutics announces 1-for-75 reverse stock split
- Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
- Navigating the Maze: Avenue Therapeutics Grapples with Regulatory Hurdles for IV Tramadol
- Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights